{"id":"https://openalex.org/W4362624813","doi":"https://doi.org/10.1158/1535-7163.22523328.v1","title":"Supplementary Figure from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death","display_name":"Supplementary Figure from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362624813","doi":"https://doi.org/10.1158/1535-7163.22523328.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22523328.v1","doi":"https://doi.org/10.1158/1535-7163.22523328.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22523328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22523328.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013497399","display_name":"William A. Blessing","orcid":"https://orcid.org/0000-0002-3145-7762","observed_orcids":["https://orcid.org/0000-0002-3145-7762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Blessing","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3145-7762","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073569663","display_name":"Christopher S. Digesu","orcid":"https://orcid.org/0000-0002-3779-1913","observed_orcids":["https://orcid.org/0000-0002-3779-1913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher S. Digesu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3779-1913","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014687555","display_name":"Rong Liu","orcid":"https://orcid.org/0000-0001-5876-1986","observed_orcids":["https://orcid.org/0000-0001-5876-1986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rong Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5876-1986","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016461513","display_name":"David A. Mahvi","orcid":"https://orcid.org/0000-0003-2722-8518","observed_orcids":["https://orcid.org/0000-0003-2722-8518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Mahvi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2722-8518","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030649022","display_name":"Aya Tal-mason","orcid":"https://orcid.org/0000-0001-6847-1579","observed_orcids":["https://orcid.org/0000-0001-6847-1579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aya Tal-mason","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6847-1579","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101719289","display_name":"Anil Kumar","orcid":"https://orcid.org/0000-0001-5242-1323","observed_orcids":["https://orcid.org/0000-0001-5242-1323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil Kumar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5242-1323","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089444106","display_name":"Krista J. Hachey","orcid":"https://orcid.org/0000-0002-4603-5490","observed_orcids":["https://orcid.org/0000-0002-4603-5490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krista J. Hachey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4603-5490","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090222497","display_name":"Aaron H. Colby","orcid":"https://orcid.org/0000-0001-7161-821X","observed_orcids":["https://orcid.org/0000-0001-7161-821X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron H. Colby","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7161-821X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073509597","display_name":"Jenny T. Korunes-Miller","orcid":"https://orcid.org/0000-0002-3300-1451","observed_orcids":["https://orcid.org/0000-0002-3300-1451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny T. Korunes-Miller","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3300-1451","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905613","display_name":"Natalie Agar","orcid":"https://orcid.org/0000-0003-3149-3146","observed_orcids":["https://orcid.org/0000-0003-3149-3146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalie Agar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3149-3146","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075621139","display_name":"Michael Scott Regan","orcid":"https://orcid.org/0000-0001-5252-2829","observed_orcids":["https://orcid.org/0000-0001-5252-2829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael S. Regan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5252-2829","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020748070","display_name":"Angela R. Shih","orcid":"https://orcid.org/0000-0002-8945-5997","observed_orcids":["https://orcid.org/0000-0002-8945-5997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Shih","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8945-5997","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056266239","display_name":"Chandrajit P. Raut","orcid":"https://orcid.org/0000-0001-7297-3221","observed_orcids":["https://orcid.org/0000-0001-7297-3221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chandrajit P. Raut","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7297-3221","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001975624","display_name":"Mark W. Grinstaff","orcid":"https://orcid.org/0000-0002-5453-3668","observed_orcids":["https://orcid.org/0000-0002-5453-3668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark W. Grinstaff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5453-3668","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034925727","display_name":"Yolonda Lorig Colson","orcid":"https://orcid.org/0000-0002-8229-5636","observed_orcids":["https://orcid.org/0000-0002-8229-5636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yolonda L. Colson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8229-5636","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.1979999989271164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8169999718666077},{"id":"https://openalex.org/keywords/supratherapeutic-drug-levels","display_name":"supratherapeutic drug levels","score":0.8519999980926514},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/cell-death","display_name":"cell death","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8478654623031616},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6442091464996338},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5459441542625427},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.394649475812912},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25836730003356934},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2581537365913391},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0828951895236969}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22523328.v1","doi":"https://doi.org/10.1158/1535-7163.22523328.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22523328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22523328","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_from_Sustained_Supratherapeutic_Paclitaxel_Delivery_Enhances_Irreversible_Sarcoma_Cell_Death/22523328","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22523328.v1","doi":"https://doi.org/10.1158/1535-7163.22523328.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22523328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4293413486","https://openalex.org/W4392690033","https://openalex.org/W7100178300","https://openalex.org/W4213077664","https://openalex.org/W6987574419","https://openalex.org/W3142085441","https://openalex.org/W4387229209","https://openalex.org/W2057721584","https://openalex.org/W2468567184","https://openalex.org/W2341852563"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"from":[2],"Sustained":[3],"Supratherapeutic":[4],"Paclitaxel":[5],"Delivery":[6],"Enhances":[7],"Irreversible":[8],"Sarcoma":[9],"Cell":[10],"Death":[11]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-07T00:00:00"}